Currently, out of the existing stock ratings of Steve Scala - 28 which are a Hold (34.57%), 50 which are a Buy (61.73%), 3 which are a Sell (3.7%)

Steve Scala

Work Performance Price Targets & Ratings Chart

Analyst Steve Scala works at TD COWEN and is covering the Healthcare sector with 163 price targets and ratings displayed on 13 stocks.

Steve Scala's average stock forecast success ratio is 76.43% with an average time for price targets to be met of 673.17 days.

Most recent stock forecast was given on BMY, BristolMyers Squibb Company at 15-Sep-2023.

Wall Street Analyst Steve Scala

Analyst best performing recommendations are on LLY (ELI LILLY AND COMPANY).
The best stock recommendation documented was for PFE (PFIZER) at 11/5/2021. The price target of $56 was fulfilled within 40 days with a profit of $9.35 (20.04%) receiving and performance score of 5.01.

Average potential price target upside

of $29.59 (23.68%) on LLY (ELI LILLY AND COMPANY).
of $26.51 (37.23%) on ABBV (ABBVIE).
of $26.02 (39.43%) on NVS (NOVARTIS AG).

ABBV AbbVie AZN AstraZeneca PLC BMY BristolMyers Squibb Company ELAN Elanco Animal Health GSK GlaxoSmithKline plc LLY Eli Lilly and Company MRK Merck . NVS Novartis AG PFE Pfizer EQRX ZTS Zoetis NVO RHHBY

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Gary Nachman (BMO)